Skip to main content
SpringerLink
Log in

Klinisch-chemische Untersuchungen

  • Chapter
Klinische Hepatologie

  • 107 Accesses

Zusammenfassung

Klinisch-chemische Untersuchungen haben einen hohen Stellenwert in der Erkennung, Differenzierung und Verlaufskontrolle von Lebererkrankungen. Hierbei erlaubt ihr von der Norm abweichendes Muster diagnostische Rückschlüsse auf Art und Lokalisation des Leberschädens. Schädigung und Tod von Leberzellen führen zur Freisetzung von Zellinhaltsstoffen in den extrazellulären Raum und in die Zirkulation. Zellenzyme sind daher sensitive Indikatoren für einen Zellschaden. Störungen des Galleflusses führen zum Anstieg der Aktivitäten biliär lokalisiserter und/oder sezernierter Substanzen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Gressner AM (1987) Pathobiochemie und klinisch-chemische Diagnostik der Organ-und Systemerkrankungen, Leber und Gallenwege. In: Greiling H, Gressner AM (Hrsg) Lehrbuch der klinischen Chemie und Pathobiochemie. Schattauer, Stuttgart, S 421–507

    Google Scholar 

  • Khan KN, Tsutsumi T, Nakata K et al. (1998) Regulation of alkaline phoshatase gene expression in human hepatoma cells by bile acids. J Gastroenterol Hepatol 13: 643–650

    Article  PubMed  CAS  Google Scholar 

  • Ravel R (1995) Clinicallaboratory medicine, 6th ed. Mosby Year Book, St. Louis

    Google Scholar 

  • Reichling JJ, Kaplan MM (1988) Clinical use of serum enzymes in liver disease. Dig Dis Sci 33: 1601–1614

    Article  PubMed  CAS  Google Scholar 

  • Schmidt E, Schmidt FW (2000) Klinisch-chemische Untersuchungsmethoden. In: Schmidt E, Schmidt FW, Manns MP (Hrsg) Lebererkrankungen. Pathophysiologie-Diagnostik-Therapie. Ein Zwischenbericht für Klinik und Praxis. Wissenschaftliche Verlagsanstalt, Stuttgart, S 8–60

    Google Scholar 

  • Thomas L (1998) Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, 5. Aufl. TH-Books Verlagsgesellschaft, Frankfurt/Main

    Google Scholar 

  • Arrigoni A, Gindro T, Aimo G et al. (1994) Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis. Hepatology 20: 383–387

    Article  PubMed  CAS  Google Scholar 

  • Balogh A, Harder S, Vollandt R et al. (1992) Intra-individual variability of caffeine elimination in healthy subjects. Int J Clin Pharmacol Ther Toxicol 30: 383–387, published erratum appears in Int J Clin Pharmacol Ther Toxicol (1993) 3: 208

    PubMed  CAS  Google Scholar 

  • Bergstrom M, Soderman C, Eriksson LS (1993) A simplified method to determine galactose elimination capacity in patients with liver disease. Scand J Clin Lab Invest 53: 667–670

    Article  PubMed  CAS  Google Scholar 

  • Brockmoller J, Roots I (1994) Assessment of liver metabolic function. Clinical implications. Clin Pharmacokinet 27: 216–248

    Article  PubMed  CAS  Google Scholar 

  • Brody DH, Leichter L (1979) Clearance tests of liver function. Med Clin North Am 63: 621–630

    PubMed  CAS  Google Scholar 

  • Caspary WF (1978) Atemanalytische Tests in der Leberfunktionsdiagnostik. Z Gastroenterol 16: 188–197

    PubMed  CAS  Google Scholar 

  • Cheng WS, Murphy TL, Smith MT et al. (1990) Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 47: 516–524

    Article  PubMed  CAS  Google Scholar 

  • Fairchild R, Solomon H, Contis J et al. (1996) Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability. Arch Surg 131: 1099–1102

    Article  PubMed  CAS  Google Scholar 

  • Farinati F, Dalri L, Rossaro L et al. (1993) Serum and salivary caffeine clearance in cirrhosis. Any role in selection for surgery and timing for transplantation? J Hepatol 18: 135–136

    Article  PubMed  CAS  Google Scholar 

  • Friedman LS, Martin P, Muñoz SJ (1996) Liver function tests and the objective evaluation of the patient with liver disease. In: Zakim D, Boyer T (eds) Hepatology — a textbook of liver disease, 3rd ed. Saunders, Philadelphia, pp 791–833

    Google Scholar 

  • Jalan R, Hayes PC (1995) Quantitative tests of liver function. Aliment Pharmacol Ther 9: 263–270

    Article  PubMed  CAS  Google Scholar 

  • Lewis FW, Rector WG Jr (1992) Caffeine clearance in cirrhosis. The value of simplified determinations of liver metabolic capacity. J Hepatol 14: 157–162

    Article  PubMed  CAS  Google Scholar 

  • Lotterer E, Hogel J, Gaus W et al. (1997) Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study. Hepatology 26: 1426–1433

    Article  PubMed  CAS  Google Scholar 

  • Maynard ND, Bihari DJ, Dalton RN et al. (1997) Liver function and splanchnic ischemia in critically ill patients. Chest 111: 180–187

    Article  PubMed  CAS  Google Scholar 

  • Merkel C, Gatta A, Zoli M et al. (1991) Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 36: 1197–1203

    Article  PubMed  CAS  Google Scholar 

  • Merkel C, Bolognesi M, Bellon S et al. (1992) Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 33: 836–842

    Article  PubMed  CAS  Google Scholar 

  • Merkel C, Marchesini G, Fabbri A et al. (1996) The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology 24: 820–823

    Article  PubMed  CAS  Google Scholar 

  • Meyer-Wyss B, Renner E, Luo H et al. (1993) Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. J Hepatol 19: 133–139

    Article  PubMed  CAS  Google Scholar 

  • Molino G, Cavanna A, Avagnina P et al. (1987) Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow. Dig Dis Sci 32: 753–758

    Article  PubMed  CAS  Google Scholar 

  • Paumgartner G (1975) The handling of indocyanine green by the liver. Schweiz Med Wochenschr 105 [suppl]: 1–30

    PubMed  CAS  Google Scholar 

  • Preisig R (1985) Fremdsubstanzen als Indikatoren der Leberfunktion. Schweiz Med Wochenschr [suppl 19]: 36–42

    CAS  Google Scholar 

  • Reichen J, Widmer T, Cotting J (1991) Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. Hepatology 14: 504–510

    Article  PubMed  CAS  Google Scholar 

  • Rosenthal SM, White EC (1925) Clinical application of bromsulphthalein test for hepatic function. JAMA 84: 1112

    Article  Google Scholar 

  • Rowntree LG, Hurwitz SH, Bloomfield AL (1913) An experimental and clinical study of the value of phenoltetrachlorphthalein as a test of hepatic function. Bull Johns Hopkins Hosp 24: 327

    Google Scholar 

  • Salerno F, Borroni G, Moser P et al. (1996) Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. J Hepatol 25: 474–480

    Article  PubMed  CAS  Google Scholar 

  • Shiffman ML, Luketic VA, Sanyal AJ et al. (1994) Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis. Hepatology 19: 933–940

    Article  PubMed  CAS  Google Scholar 

  • Stremmel W, Wojdat R, Groteguth R et al. (1992) Leberfunktionstests im klinischen Vergleich. Z Gastroenterol 30: 784–790

    PubMed  CAS  Google Scholar 

  • Tygstrup N (1990) Assessment of liver function: principles and practice. J Gastroenterol Hepatol 5: 468–482

    Article  PubMed  CAS  Google Scholar 

  • Wahlländer A, Beuers U (1990) Prognostischer Wert von Leberfunktionstests — Klinik, laborchemische Parameter und quantitative Funktionstests. Leber Magen Darm 20: 115–116,119–123,126–128

    PubMed  Google Scholar 

  • Wahlländer A, Mohr S, Paumgartner G (1990) Assessment of hepatic function. Comparison of caffeine clearance in serum and saliva during the day and at night. J Hepatol 10: 129–137

    Article  PubMed  Google Scholar 

  • Abuaf N, Johanet C, Chretien P et al. (1992) Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology 16: 892–898

    Article  PubMed  CAS  Google Scholar 

  • Berg PA, Klein R (1992) Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance. Dig Dis Sci 10: 85–101

    Article  CAS  Google Scholar 

  • Czaja AJ (1996) Autoimmune liver disease. In: Zakim D, Boyer TD (eds) Hepatology — a textbook of liver disease, 3rd ed. Saunders, Philadelphia London Toronto Montreal Sydney Tokyo, pp 1259–1292

    Google Scholar 

  • Czaja AJ, Nishioka M, Morshed SA et al. (1994) Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107: 200–207

    PubMed  CAS  Google Scholar 

  • Czaja AJ, Cassani F, Cataleta M et al. (1996) Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068–1073

    Article  PubMed  CAS  Google Scholar 

  • Czaja AJ, Pfeifer KD, Decker RH et al. (1996) Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 4: 1733–1740

    Article  Google Scholar 

  • Czaja AJ, Homburger HA (2001) Autoantibodies in liver disease. Gastroenterology 120: 239–249

    Article  PubMed  CAS  Google Scholar 

  • Dancygier H, Frühauf H (1997) Klinische Pharmakologie der Leberkrankheiten. In: Kuemmerle (Hrsg) Klinische Pharmakologie, 4. Aufl., Kap IV — 4.11.1. Ecomed, 1Landsberg, S 1–77

    Google Scholar 

  • Duerr RH, Targan SR, Landers CJ et al. (1991) Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100: 1385–1391

    PubMed  CAS  Google Scholar 

  • García-Buey L, García-Monzón C, Rodriguez S et al. (1995) Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770–1777

    Article  PubMed  Google Scholar 

  • Gross WL, Hauschild S, Schmitt WH (1993) Immundiagnostische und immunpathogenetische Bedeutung von AntiNeutrophilen-Zytoplasma-Antikörpern. Dtsch Med Wochenschrl 18: 191–199

    Article  Google Scholar 

  • Halbwachs-Mecarelli L, Nusbaum P, Noel LH et al. (1992) Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn’s disease and primary sclerosing cholangitis. Clin Exp Immunol 90: 79–84

    Article  PubMed  CAS  Google Scholar 

  • Kernebeck T, Lohse AW, Grotzinger J et al. (2001) A Biolnformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigenlliver pancreas. Hepatology 34: 230–233

    Article  PubMed  CAS  Google Scholar 

  • Klein R, Berg PA (1990) Demonstration of “naturally occurring mitochondrial antibodies” in family members of patients with primary biliary cirrhosis. Hepatology 12: 335–341

    Article  PubMed  CAS  Google Scholar 

  • Klein R, Huizenga JR, Gips CH et al. (1994) Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol 20: 181–189

    Article  PubMed  CAS  Google Scholar 

  • Klein R, Kloppel G, Garbe W et al. (1991) Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6–18 years. J Hepatol 12: 21–27

    Article  PubMed  CAS  Google Scholar 

  • Manns M (1989) Autoantibodies and antigens in liver diseases — updated. J Hepatol 9: 272–280

    Article  PubMed  CAS  Google Scholar 

  • Manns MP, Johnson EF, Griffin KJ et al. (1989) Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 83: 1066–1072

    Article  PubMed  CAS  Google Scholar 

  • Manns MP, Griffin KJ, Sullivan KF et al. (1991) LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88: 1370–1378

    Article  PubMed  CAS  Google Scholar 

  • Mayet WJ, Orth T, Schwarting A et al. (1996) Die Bedeutung antineutrophiler zytoplasmatischer Antikörper (ANCA) in der Diagnostik und Immunpathogenese chronisch entzündlicher Lebererkrankungen. Med Klin 91: 384–388

    CAS  Google Scholar 

  • McFarlane IG, Hegarty JE, McSorley CG et al. (1984) Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 2:954–956

    Google Scholar 

  • Meyer zum Büschenfelde KH, Gerken G (1996) Immune mechanisms in the production of liver disease. In: Zakim D, Boyer TD (eds) Hepatology: a textbook of liver disease, 3rd ed. Saunders, Philadelphia London Toronto Montral Sydney Tokyo, PP 1243–1258

    Google Scholar 

  • Philipp T, Durazzo M, Trautwein C et al. (1994) Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet 344: 578–581

    Article  PubMed  CAS  Google Scholar 

  • Poupon R, Poupon RE (1996) Primary biliary cirrhosis. In: Zakim D, Boyer TD (eds) Hepatology: a textbookof liver disease, 3rd ed. Saunders, Philadelphia London Toronto Montral Sydney Tokyo, pp 1329–1365

    Google Scholar 

  • Scibold F, Slametschka D, Gregor M et al. (1994) Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107: 532–536

    Google Scholar 

  • Szostecki C, Will H, Netter HJ et al. (1992) Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand J Immunol 36: 555–564

    Article  PubMed  CAS  Google Scholar 

  • Targan SR, Landers C, Vidrich A et al. (1995) High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108: 1159–1166

    Article  PubMed  CAS  Google Scholar 

  • Thomas L (1992) Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die Medizinische Diagnostik. Autoantikörper gegen Organgewebe und Thrombozyten 4. Aufl. Medizinische Verlagsgesellschaft, Marburg

    Google Scholar 

  • Toh BH (1979) Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 38: 621–628

    PubMed  CAS  Google Scholar 

  • Treichel U, McFarlane BM, Seki T et al. (1994) Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 107: 799–804

    Article  PubMed  CAS  Google Scholar 

  • Treichel U, Paietta E, Poralla T et al. (1994) Effects of cytokines on synthesis and function of the hepatic asialoglycoprotein receptor. J Cell Physiol 158: 527–534

    Article  PubMed  CAS  Google Scholar 

  • Vierling JM (1996) Hepatobiliary complications of ulcerative colitis and Crohns’ disease. In: Zakim D, Boyer TD (eds) Hepatology: a textbook of liver disease, 3rd ed. Saunders, Philadelphia London Toronto Montreal Sydney Tokyo, pp 1366–1405

    Google Scholar 

  • Wachter B, Kyriatsoulis A, Lohse AW et al. (1990) Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol 11: 232–239

    Article  PubMed  CAS  Google Scholar 

  • Wesierska-Gadek J, Grimm R, Hitchman E et al. (1998) Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology 114: 329–335

    Article  PubMed  CAS  Google Scholar 

  • Wies I, Brunner S, Henninger J et al. (2000) Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355: 1510–1515

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto AM, Cresteil D, Homberg JC et al. (1993) Characterization of anti-liver-kidney microsome antibody (antiLKM1) from hepatitis C virus-positive and-negative sera. Gastroenterology 104: 1762–1767

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Dancygier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Frühauf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H., Frühauf, H. (2003). Klinisch-chemische Untersuchungen. In: Klinische Hepatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55902-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55902-0_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67559-4

  • Online ISBN: 978-3-642-55902-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation